Similar articles for PMID: 19629679

Year	Number of Results
2001	1
2004	2
2005	3
2006	7
2007	8
2008	11
2009	16
2010	18
2011	15
2012	9
2013	3
2014	10
2015	4
2016	4
2017	5
2018	1
2019	9
2020	2
2021	2
2022	2
2023	1
2024	0

1

Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP. Sergentanis TN, et al. Breast Cancer Res Treat. 2010 Feb;120(1):229-34. doi: 10.1007/s10549-009-0471-5. Epub 2009 Jul 24. Breast Cancer Res Treat. 2010. PMID: 19629679

2

Functional variants in cell death pathway genes and risk of pancreatic cancer.

Yang M, Sun T, Wang L, Yu D, Zhang X, Miao X, Liu J, Zhao D, Li H, Tan W, Lin D. Yang M, et al. Clin Cancer Res. 2008 May 15;14(10):3230-6. doi: 10.1158/1078-0432.CCR-08-0177. Clin Cancer Res. 2008. PMID: 18483392

3

Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.

Hashemi M, Eskandari-Nasab E, Fazaeli A, Rezaei H, Mashhadi MA, Arbabi F, Taheri M. Hashemi M, et al. Gene. 2012 Aug 15;505(1):176-9. doi: 10.1016/j.gene.2012.05.043. Epub 2012 Jun 1. Gene. 2012. PMID: 22659694 Clinical Trial.

4

The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.

Ji GH, Li M, Cui Y, Wang JF. Ji GH, et al. Cell Mol Biol (Noisy-le-grand). 2014 Dec 30;60(6):20-8. Cell Mol Biol (Noisy-le-grand). 2014. PMID: 25553350

5

CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.

Zhang F, Yang Y, Guo C, Wang Y. Zhang F, et al. Mutagenesis. 2012 Sep;27(5):559-66. doi: 10.1093/mutage/ges019. Epub 2012 Apr 18. Mutagenesis. 2012. PMID: 22513478

6

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.

Palanca Suela S, Esteban Cardeñosa E, Barragán González E, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Montalar Salcedo J, Castel Sánchez V, Bolufer Gilabert P; Group for Assessment of Hereditary Cancer of Valencia Community. Palanca Suela S, et al. Breast Cancer Res Treat. 2010 Jan;119(1):87-93. doi: 10.1007/s10549-009-0316-2. Epub 2009 Feb 12. Breast Cancer Res Treat. 2010. PMID: 19214744

7

Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.

Zhang CD, Li HT, Liu K, Lin ZD, Peng QL, Qin X, He M, Wu H, Mo ZN, Yang XL. Zhang CD, et al. Asian Pac J Cancer Prev. 2014;15(18):7713-8. doi: 10.7314/apjcp.2014.15.18.7713. Asian Pac J Cancer Prev. 2014. PMID: 25292051 Free article.

8

CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.

Han S, Lee KM, Choi JY, Park SK, Lee JY, Lee JE, Noh DY, Ahn SH, Han W, Kim DH, Hong YC, Ha E, Yoo KY, Kang D. Han S, et al. Breast Cancer Res Treat. 2008 Jul;110(2):387-93. doi: 10.1007/s10549-007-9730-5. Epub 2007 Oct 17. Breast Cancer Res Treat. 2008. PMID: 17940865

9

CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.

Li Z, Wang J, Wang F, Ma Z, Yu Z. Li Z, et al. Neth J Med. 2014 Jan;72(1):10-6. Neth J Med. 2014. PMID: 24457433 Free article. Review.

10

The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.

de Martino M, Haitel A, Schatzl G, Klingler HC, Klatte T. de Martino M, et al. J Urol. 2013 Aug;190(2):717-22. doi: 10.1016/j.juro.2013.01.008. Epub 2013 Jan 9. J Urol. 2013. PMID: 23313206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

109 results

Results by year